NCT07025941

Brief Summary

This combined intervention protocol effectively improves the prognosis of critically ill patients and optimizes nursing management models

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 2, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2024

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2024

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 18, 2025

Completed
Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

June 9, 2025

Last Update Submit

June 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • ICU Length of Stay (LOS)

    Calendar days from ICU admission to discharge criteria met (APACHE II score ≤10, hemodynamic stability for ≥24h).

    From randomization to ICU discharge, up to 60 days

Secondary Outcomes (1)

  • Incidence of Pulmonary Infections

    From ICU admission to 48 hours post-extubation or 14-day intervention period

Other Outcomes (1)

  • Protocol Adherence Rate

    Daily during 14-day intervention

Study Arms (2)

control group

OTHER
Other: Standard Critical Care Nursing Protocol

intervention group

EXPERIMENTAL
Behavioral: ICU-PRO Nursing Protocol (Integrated Critical Care Protocol for Rehabilitation Outcomes)

Interventions

The Standard Critical Care Nursing Protocol encompasses evidence-based, routine nursing practices for critically ill patients in the intensive care unit (ICU). This protocol serves as the control intervention in comparative studies evaluating novel nursing strategies. Key Components: Basic Physiological Monitoring: Continuous assessment of vital signs (heart rate, blood pressure, respiratory rate, SpO₂). Strict intake/output monitoring and electrolyte balance management. Airway Management: Standard oxygen therapy (nasal cannula, face mask) or mechanical ventilation as prescribed. Scheduled suctioning, positional changes, and oral care (every 4-6 hours). Infection Prevention: Aseptic techniques for invasive procedures (e.g., central line care, urinary catheter management). Ventilator-associated pneumonia (VAP) bundle compliance (e.g., head-of-bed elevation, sedation vacations). Mobility \& Skin Integrity: Passive range-of-motion exercises for immobilized patients (2×/day). Pr

control group

The intervention group received a standardized 14-day nursing protocol combining three evidence-based components: Comprehensive Rehabilitation Nursing: Early mobilization protocol with passive/active exercises (3-4 sessions/day) Respiratory training using incentive spirometry (Triflo II® devices) Swallowing rehabilitation with VitalStim® electrical stimulation Refined Airway Management: Humidification via Fisher \& Paykel® MR850 systems (33-44 mg/L) Closed suction systems (Ballard® Trach Care) with strict aseptic technique Oral care with 0.12% chlorhexidine solution (Peridex®) 4×/day Nutritional Support: Enteral feeding using Abbott Nutrition® formulas Parenteral nutrition via Baxter®/Fresenius Kabi® solutions Gastric residual monitoring with Kangaroo™ feeding pumps Key Features: Implemented by specialized ICU nurses, respiratory therapists, and dietitians Daily monitoring using Philips® IntelliVue patient monitors Protocol adjustments based on weekly APACHE II scoring

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fulfillment of ICU admission standards with critical illness confirmed by attending physicians or senior specialists
  • Age ≥ 18 years
  • Stable vital signs:
  • Systolic blood pressure ≥ 90 mmHg and ≤ 180 mmHg
  • Heart rate ≤ 120 beats/min
  • Oxygen saturation (SpO₂) ≥ 85% under ≤ 60% fraction of inspired oxygen (FiO₂)
  • Intact or tolerable gastrointestinal (GI) function for enteral nutrition

You may not qualify if:

  • Terminal malignancies
  • Brain death
  • Irreversible organ failure (e.g., end-stage cirrhosis, advanced heart failure)
  • Comorbidities potentially confounding study outcomes
  • Contraindications to interventions (e.g., laryngeal edema, complete intestinal obstruction)
  • Pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taizhou Hospital of Traditional Chinese Medicine

Taizhou, Jiangsu, 225300, China

Location

MeSH Terms

Conditions

Gastrointestinal HemorrhageAcute Kidney Injury

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 9, 2025

First Posted

June 18, 2025

Study Start

June 2, 2023

Primary Completion

June 5, 2024

Study Completion

June 23, 2024

Last Updated

June 18, 2025

Record last verified: 2025-06

Locations